Quality improvement initiative to improve revaccination rates after autologous stem cell transplantation

[摘要] Patients undergoing autologous haematopoietic stem cell transplants (ASCT) lose theiracquired immunity against various pathogensdue to reset and weakening of the immunesystem.1 As such, Ontario Health guidelinesrecommend reimmunising these patientsagainst vaccine-preventable diseases beginning 4–6 months post-transplant.2 LondonHealth Sciences Centre (LHSC) performsapproximately 80–90 ASCT procedures annually for haematological malignancies such asmultiple myeloma, non-Hodgkin’s lymphomaand Hodgkin’s lymphoma. The LHSC ASCTteam routinely disseminates recommendations for revaccination, but prior to thisproject local data regarding adherence tothese recommendations was not available.As such, this quality improvement projectaimed to assess compliance with post-ASCTvaccinations at LHSC, and to explore ways toimprove this compliance.

[学科分类] 药学

[关键词] Quality improvement;Vaccination;Compliance;Surveys;Communication